Pharming Group N.V. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Pharming Group

Pharming Group

Pharming Group N.V.
Stock Exchange	Other OTC
EPS	$0.09
Market Cap	$526.57 M
Shares Outstanding	609.68 M
Public Float	-

Pharming Group N.V.
Stock Exchange	Euronext - Alternext Amsterdam
EPS	EUR0.08
Market Cap	EUR471.22 M
Shares Outstanding	621.5 M
Public Float	592.81 M

Pharming Group N.V.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	609.68 M
Public Float	-

Profile

Address	Darwinweg 24 Leiden Zuid-Holland 2333 CR Netherlands
Employees	-
Website	http://www.pharming.com
Updated	07/08/2019
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World.

Financials

Paul Jai Sekhri

Chairman-Supervisory Board

Jaap Blaak

Independent Member-Supervisory Board